Literature DB >> 7674251

Behçet's disease induced by interferon therapy for chronic myelogenous leukemia.

F Segawa1, Y Shimizu, E Saito, M Kinoshita.   

Abstract

A 59-year-old Japanese woman, diagnosed with mixed connective tissue disease (MCTD) and chronic myelogenous leukemia (CML), developed several characteristic features of Behçet's disease (BD) after receiving alpha-interferon (IFN-alpha). She displayed recurrent oral aphtha, genital ulceration, erythema nodosum at the bilateral arm, and low grade fever. The skin of the femur where the IFN-alpha was injected showed modular acneiform changes. Skin biopsy revealed perivascular infiltration. The symptoms compatible with BD improved after discontinuation of IFN-alpha and the introduction of prednisolone and azathioprine. This is the first description of BD induced by IFN-alpha.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674251

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

2.  Panuveitis simulating ocular Behçet's in cases of chronic myelogenous leukaemia in remission.

Authors:  Rohan Chawla; Koushik Tripathy
Journal:  BMJ Case Rep       Date:  2017-11-23

Review 3.  Behçet's disease and comorbidity: internal case reports and literature review.

Authors:  Zemfira Alekberova; Vadim Gorodetskiy; Fatima Izmailova; Stefka Radenska-Lopovok; Elnura Talybova; Margarita Evsikova; Nikolai Timoshin; Evgeni Nasonov
Journal:  Rheumatol Int       Date:  2015-02-13       Impact factor: 2.631

4.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Authors:  I Kötter; A K Eckstein; N Stübiger; M Zierhut
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

6.  Pegylated Interferon-Induced Sarcoidosis Presenting With Anterior Uveitis in a Patient with Chronic Hepatitis C - Case Report.

Authors:  A M Kamal; P Mitruț; C K Kamal; D O Alexandru; A Tica
Journal:  Curr Health Sci J       Date:  2015-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.